Leerink Swann Reiterates on Aegerion Pharmaceuticals as Weakness is Overdone UPDATE: Leerink Swann Initiates Coverage on WellPoint as There is Upside Amid the Winds of Change UPDATE: Leerink Swann ...

In a dramatic turnaround from bankruptcy court less than two years ago, Leerink Partners is now on the offensive and hiring ...

Leerink Partnrs currently has a “Strong-Buy” rating on the stock. The consensus estimate for Beam Therapeutics’ current full-year earnings is ($4.64) per share.

Moderna's (NASDAQ:MRNA) mRNA-1647, its vaccine asset for cytomegalovirus (CMV), may not yield positive interim phase 3 data when it could be released by the end of the month, according to Leerink.

Leerink analyst Joseph Schwartz notes Outperform-rated Sarepta (SRPT) disclosed two-year Part 1 and one-year Part 2 data from the EMBARK study with Elevidys. The firm views these topline results ...

Leerink Partnrs also issued estimates for Arcturus Therapeutics’ Q4 2024 earnings at ($0.66) EPS, Q1 2025 earnings at ($0.07) EPS, Q2 2025 earnings at ($0.80) EPS and Q4 2025 earnings at ($0.79 ...

Upstart investment bank SVB Leerink is no longer keeping mum on its ambitions to push into the red hot technology, media, and telecommunications market. The dealmaking unit of SVB Financial Group ...

Leerink lowered the firm’s price target on Tenaya Therapeutics (TNYA) to $6 from $8 and keeps an Outperform rating on the shares after the company announced initial Phase 1b/2 MyPEAK-1 data for ...

Leerink analyst Daniel Clark initiated coverage of Zoetis (ZTS) with an Outperform rating and $215 price target The firm notes . Zoetis has been one of the best performing names in animal health ...

On Monday, Leerink Partners sustained their Outperform rating and $110.00 price target for Axsome Therapeutics (NASDAQ:AXSM) shares. The firm's stance comes in the wake of recent clinical trial ...

On Monday, Progyny (NASDAQ:PGNY) shares saw a change in their market prospects as Leerink Partners adjusted the company's price target. Analysts at Leerink Partners increased the price target on ...